Al Achkar M, Grannis S, Revere D, et al. The effects of state rules on opioid prescribing in Indiana. BMC Health Serv Res. 2018;18(1):29.  Article
Baehren DF, Marco CA, Droz DE, et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010;56(1):19-23.e1-3.  Abstract
Bao Y, Pan Y, Taylor A, et al. Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Aff (Millwood). 2016;35(6):1045-51.  Article
Bohnert ASB, Guy GP, Losby JL. Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention’s 2016 Opioid Guideline. Ann Intern Med. 2018;169(6):367-75.  Article
Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458-65.  Article
Chang HY, Lyapustina T, Rutkow L, et al. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. Drug Alcohol Depend. 2016;165:1-8.  Article
Conklin J, Farrell B, Ward N, et al. Developmental evaluation as a strategy to enhance the uptake and use of deprescribing guidelines: protocol for a multiple case study. Implement Sci. 2015;10:91.  Article
Deyo RA, Irvine JM, Hallvik SE, et al. Leading a horse to water: facilitating registration and use of a prescription drug monitoring program. Clin J Pain. 2015;31(9):782-7.  Article
Dormuth CR, Miller TA, Huang A, et al.  Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines. CMAJ. 2012;184:(16):E852-6.  Article
Farrell B, Richardson L, Raman-Wilms L, et al. Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines. Res Social Adm Pharm. 2017 Jan 28. pii: S1551-7411(17)30055-4. [Epub]  Abstract
Farrell B, Tsang C, Raman-Wilms L, et al. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. PLoS One. 2015;10(4):e0122246.  Article
Franklin GM, Mai J, Turner J, et al. Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med. 2012;55(4):325-31. Abstract
Fisher J, Sanyal C, Frail D, Sketris I. The intended and unintended consequences of benzodiazepine monitoring programs: a review of the literature. J Clin Pharm Ther. 2012;37(1):7-21.  Abstract
Fulton-Kehoe D, Garg RK, Turner JA, et al. Opioid poisonings and opioid adverse effects in workers in Washington State. Am J Ind Med. 2013  Abstract
Gaither JR, Goulet JL, Becker WC, et al. The association between receipt of guideline – concordant long-term opioid therapy and all-cause mortality. J Gen Intern Med. 2016;31(5):492-501.  Abstract
Garg RK, Fulton-Kehoe D, Turner JA, et al. Changes in opioid prescribing for Washington workers’ compensation claimants after implementation of an opioid dosing guideline for chronic noncancer pain: 2004 to 2010. J Pain. 2013;14(12):1620-8.  Abstract
Green TC, Mann MR, Bowman SE, et al. How does use of a prescription monitoring program change medical practice? Pain Med. 2012;13(10):1314-23.  Abstract
Hamill-Ruth RJ, Larriviere K, McMasters MG. Addition of objective data to identify risk for medication misuse and abuse: the inconsistency score. Pain Med. 2013;14(12):1900-7.  Abstract
Jeffery MM, Hooten WM, Jena AB, et al. Rates of physician coprescribing of opioids and benzodiazepines after the release of the Centers for Disease Control and prevention guidelines in 2016. JAMA Netw Open. 2019;2(8):e198325.  Article
Kashyap M, D’Cruz S, Sachdev A, Tiwari P. Evidence-based information leads to reduction in inappropriate drug prescribing: Results from Indian older inpatients. Int J Risk Saf Med. 2015;27(4):209-17.  Abstract
Lina H-C, Wanga Z, Boydb C, et al. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain. Addict Behav. 2018;76:348-54.  Abstract
Maine BZ guideline workgroup
Neubauer MA, Hoverman JR, Kolodziej M, et al. Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. J Oncol Pract. 2010;6(1):12-8.  Article
Oldenhof E, Anderson-Wurf J, Hall K, Staiger PK. Beyond prescriptions monitoring programs: the importance of having the conversation about benzodiazepine use. J Clin Med. 2019;8(12).  Article
Patrick SW, Fry CE, Jones TF, Buntin MB. Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff (Millwood). 2016;35(7):1324-32.  Article
Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12(5):747-54.  Abstract
Pearson S-A, Soumerai S, Mah C, et al. Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Intern Med. 2006;166(5):572-9.  Article
Reifler LM, Droz D, Bailey JE, et al. Do prescription monitoring programs impact state trends in opioid abuse / misuse? Pain Med. 2012;13(3):434-42.  Abstract
Rutkow L, Chang HY, Daubresse M, et al. Effect of Florida’s prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Intern Med. 2015;175(10):1642-9.  Abstract
Sekhon R, Aminjavahery N, Davis CN, et al. Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC). Pain Med. 2013;14(10):1548-56.  Abstract
Soelberg CD, Brown RE, Du Vivier D, et al. The US opioid crisis: current federal and state legal issues. Anesth Analg. 2017;125(5):1675-81.  Abstract
Starcevic V. Will the RANZCP clinical practice guidelines for the treatment of anxiety disorders assist in making adequate treatment decisions for panic disorder? Aust N Z J Psychiatry. 2018:4867418818362.  [Epub]  Link
Weiner SG, Baker O, Poon SJ, et al. The effect of opioid prescribing guidelines on prescriptions by emergency physicians in Ohio. Ann Emerg Med. 2017;70(6):799-808.e1.  Abstract
Weintraub M, Singh S, Byrne L, et al. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. JAMA. 1991;266:2392-7.  Abstract